These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

904 related articles for article (PubMed ID: 36503495)

  • 1. The multitarget fecal immunochemical test versus the fecal immunochemical test for programmatic colorectal cancer screening: a cross-sectional intervention study with paired design.
    Wisse PHA; de Klaver W; van Wifferen F; Meiqari L; Bierkens M; Greuter MJE; Carvalho B; van Leerdam ME; Spaander MCW; Dekker E; Coupé VMH; de Wit M; Meijer GA
    BMC Cancer; 2022 Dec; 22(1):1299. PubMed ID: 36503495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The multitarget faecal immunochemical test for improving stool-based colorectal cancer screening programmes: a Dutch population-based, paired-design, intervention study.
    Wisse PHA; de Klaver W; van Wifferen F; van Maaren-Meijer FG; van Ingen HE; Meiqari L; Huitink I; Bierkens M; Lemmens M; Greuter MJE; van Leerdam ME; Spaander MCW; Dekker E; Coupé VMH; Carvalho B; de Wit M; Meijer GA
    Lancet Oncol; 2024 Mar; 25(3):326-337. PubMed ID: 38346438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Validation of a Multitarget Fecal Immunochemical Test for Colorectal Cancer Screening : A Diagnostic Test Accuracy Study.
    de Klaver W; Wisse PHA; van Wifferen F; Bosch LJW; Jimenez CR; van der Hulst RWM; Fijneman RJA; Kuipers EJ; Greuter MJE; Carvalho B; Spaander MCW; Dekker E; Coupé VMH; de Wit M; Meijer GA
    Ann Intern Med; 2021 Sep; 174(9):1224-1231. PubMed ID: 34280333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular stool testing as an alternative for surveillance colonoscopy: a cross-sectional cohort study.
    van Lanschot MC; Carvalho B; Coupé VM; van Engeland M; Dekker E; Meijer GA
    BMC Cancer; 2017 Feb; 17(1):116. PubMed ID: 28173852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Personalized colorectal cancer screening: study protocol of a mixed-methods study on the effectiveness of tailored intervals based on prior f-Hb concentration in a fit-based colorectal cancer screening program (PERFECT-FIT).
    Breekveldt ECH; Toes-Zoutendijk E; de Jonge L; Spaander MCW; Dekker E; van Kemenade FJ; van Vuuren AJ; Ramakers CRB; Nagtegaal ID; van Leerdam ME; Lansdorp-Vogelaar I
    BMC Gastroenterol; 2023 Feb; 23(1):45. PubMed ID: 36814185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multitarget Stool RNA Test for Colorectal Cancer Screening.
    Barnell EK; Wurtzler EM; La Rocca J; Fitzgerald T; Petrone J; Hao Y; Kang Y; Holmes FL; Lieberman DA
    JAMA; 2023 Nov; 330(18):1760-1768. PubMed ID: 37870871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of two faecal immunochemical tests for the detection of advanced neoplasia at different positivity thresholds: a cross-sectional study of the Dutch national colorectal cancer screening programme.
    de Klerk CM; Wieten E; Lansdorp-Vogelaar I; Bossuyt PM; Spaander MC; Dekker E
    Lancet Gastroenterol Hepatol; 2019 Feb; 4(2):111-118. PubMed ID: 30497962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Equivalency of fecal immunochemical tests and colonoscopy in familial colorectal cancer screening.
    Quintero E; Carrillo M; Gimeno-García AZ; Hernández-Guerra M; Nicolás-Pérez D; Alonso-Abreu I; Díez-Fuentes ML; Abraira V
    Gastroenterology; 2014 Nov; 147(5):1021-30.e1; quiz e16-7. PubMed ID: 25127679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fecal immunochemical test in cancer screening - colonoscopy outcome in FIT positives and negatives.
    Ribbing Wilén H; Blom J; Höijer J; Andersson G; Löwbeer C; Hultcrantz R
    Scand J Gastroenterol; 2019 Mar; 54(3):303-310. PubMed ID: 30907196
    [No Abstract]   [Full Text] [Related]  

  • 10. Screening for Colorectal Cancer With Fecal Immunochemical Testing With and Without Postpolypectomy Surveillance Colonoscopy: A Cost-Effectiveness Analysis.
    Greuter MJE; de Klerk CM; Meijer GA; Dekker E; Coupé VMH
    Ann Intern Med; 2017 Oct; 167(8):544-554. PubMed ID: 28973514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Increasing Screening Age and Fecal Hemoglobin Cutoff Concentrations in a Colorectal Cancer Screening Program.
    Wieten E; Schreuders EH; Nieuwenburg SA; Hansen BE; Lansdorp-Vogelaar I; Kuipers EJ; Bruno MJ; Spaander MC
    Clin Gastroenterol Hepatol; 2016 Dec; 14(12):1771-1777. PubMed ID: 27567693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Faecal immunochemical tests versus colonoscopy for post-polypectomy surveillance: an accuracy, acceptability and economic study.
    Atkin W; Cross AJ; Kralj-Hans I; MacRae E; Piggott C; Pearson S; Wooldrage K; Brown J; Lucas F; Prendergast A; Marchevsky N; Patel B; Pack K; Howe R; Skrobanski H; Kerrison R; Swart N; Snowball J; Duffy SW; Morris S; von Wagner C; Halloran S
    Health Technol Assess; 2019 Jan; 23(1):1-84. PubMed ID: 30618357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lower Abnormal Fecal Immunochemical Test Cut-Off Values Improve Detection of Colorectal Cancer in System-Level Screens.
    Berry E; Miller S; Koch M; Balasubramanian B; Argenbright K; Gupta S
    Clin Gastroenterol Hepatol; 2020 Mar; 18(3):647-653. PubMed ID: 31085338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic Yield of One-Time Colonoscopy vs One-Time Flexible Sigmoidoscopy vs Multiple Rounds of Mailed Fecal Immunohistochemical Tests in Colorectal Cancer Screening.
    Grobbee EJ; van der Vlugt M; van Vuuren AJ; Stroobants AK; Mallant-Hent RC; Lansdorp-Vogelaar I; Bossuyt PMM; Kuipers EJ; Dekker E; Spaander MCW
    Clin Gastroenterol Hepatol; 2020 Mar; 18(3):667-675.e1. PubMed ID: 31419575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advanced serrated polyps as a target of screening: detection rate and positive predictive value within a fecal immunochemical test-based colorectal cancer screening population.
    van Toledo DEFWM; Breekveldt ECH; IJspeert JEG; van Vuuren AJ; van Kemenade FJ; Ramakers C; Nagtegaal ID; van Leerdam ME; Spaander MCW; Lansdorp-Vogelaar I; Toes-Zoutendijk E; Dekker E
    Endoscopy; 2023 Jun; 55(6):526-534. PubMed ID: 36323332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel Stool-Based Protein Biomarkers for Improved Colorectal Cancer Screening: A Case-Control Study.
    Bosch LJW; de Wit M; Pham TV; Coupé VMH; Hiemstra AC; Piersma SR; Oudgenoeg G; Scheffer GL; Mongera S; Sive Droste JT; Oort FA; van Turenhout ST; Larbi IB; Louwagie J; van Criekinge W; van der Hulst RWM; Mulder CJJ; Carvalho B; Fijneman RJA; Jimenez CR; Meijer GA
    Ann Intern Med; 2017 Dec; 167(12):855-866. PubMed ID: 29159365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fecal immunochemical test in colorectal cancer screening: Colonoscopy findings by different cut-off levels.
    Ribbing Wilén H; Blom J; Höijer J; Hultcrantz R
    J Gastroenterol Hepatol; 2019 Jan; 34(1):103-112. PubMed ID: 29968937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening uptake of colonoscopy versus fecal immunochemical testing in first-degree relatives of patients with non-syndromic colorectal cancer: A multicenter, open-label, parallel-group, randomized trial (ParCoFit study).
    González-López N; Quintero E; Gimeno-Garcia AZ; Bujanda L; Banales J; Cubiella J; Salve-Bouzo M; Herrero-Rivas JM; Cid-Delgado E; Alvarez-Sanchez V; Ledo-Rodríguez A; de-Castro-Parga ML; Fernández-Poceiro R; Sanromán-Álvarez L; Santiago-Garcia J; Herreros-de-Tejada A; Ocaña-Bombardo T; Balaguer F; Rodríguez-Soler M; Jover R; Ponce M; Alvarez-Urturi C; Bessa X; Roncales MP; Sopeña F; Lanas A; Nicolás-Pérez D; Adrián-de-Ganzo Z; Carrillo-Palau M; González-Dávila E;
    PLoS Med; 2023 Oct; 20(10):e1004298. PubMed ID: 37874831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multitarget Stool DNA Test Performance in an Average-Risk Colorectal Cancer Screening Population.
    Bosch LJW; Melotte V; Mongera S; Daenen KLJ; Coupé VMH; van Turenhout ST; Stoop EM; de Wijkerslooth TR; Mulder CJJ; Rausch C; Kuipers EJ; Dekker E; Domanico MJ; Lidgard GP; Berger BM; van Engeland M; Carvalho B; Meijer GA
    Am J Gastroenterol; 2019 Dec; 114(12):1909-1918. PubMed ID: 31764091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of the OC Sensor
    Vitellius C; Laly M; Banaszuk AS; Deherce I; Cornet N; Bertrais S; Saulnier P; Caroli-Bosc FX
    Eur J Epidemiol; 2019 Feb; 34(2):163-172. PubMed ID: 30536183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.